Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Business
  • Published:

Painkiller in the dock

Nature volume 436, page 459 (2005)Cite this article

Still reeling from the loss of its blockbuster pill Vioxx, Merck is now in court to face its first lawsuit over the drug. Meredith Wadman reports.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Related links

Related links

Related links in Nature Research

Drug safety on trial

Drug safety special: The safety catch

Vioxx may go back on sale after scraping past FDA panel

Related external links

Merck

Rights and permissions

Reprints and permissions

About this article

Cite this article

Painkiller in the dock. Nature 436, 459 (2005). https://doi.org/10.1038/436459a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/436459a

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing